These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18377823)

  • 1. Hedgehog signaling pathway: development of antagonists for cancer therapy.
    Xie J
    Curr Oncol Rep; 2008 Mar; 10(2):107-13. PubMed ID: 18377823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of hedgehog signaling antagonists for cancer therapy.
    Xie J
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):670-80. PubMed ID: 18604459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications.
    Yang L; Xie G; Fan Q; Xie J
    Oncogene; 2010 Jan; 29(4):469-81. PubMed ID: 19935712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Hedgehog pathway in gastrointestinal cancers.
    Yang L; Su X; Xie J
    Vitam Horm; 2012; 88():461-72. PubMed ID: 22391316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
    Yun JI; Kim HR; Park H; Kim SK; Lee J
    Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the therapeutic potential of the Hedgehog pathway in cancer.
    Amakye D; Jagani Z; Dorsch M
    Nat Med; 2013 Nov; 19(11):1410-22. PubMed ID: 24202394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold hopping approach to a new series of smoothened antagonists.
    Lu W; Geng D; Sun Z; Yang Z; Ma H; Zheng J; Zhang X
    Bioorg Med Chem Lett; 2014 May; 24(10):2300-4. PubMed ID: 24726807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
    Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
    FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GLI factors to inhibit the Hedgehog pathway.
    Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
    Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
    Ruiz i Altaba A
    Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
    Peukert S; Miller-Moslin K
    ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulators of the hedgehog signaling pathway.
    Heretsch P; Tzagkaroulaki L; Giannis A
    Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog Signaling and Truncated GLI1 in Cancer.
    Doheny D; Manore SG; Wong GL; Lo HW
    Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
    Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
    Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Hedgehog Antagonists for Cancer Therapy.
    Khatra H; Bose C; Sinha S
    Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila Segment Polarity Mutants and the Rediscovery of the Hedgehog Pathway Genes.
    Ingham PW
    Curr Top Dev Biol; 2016; 116():477-88. PubMed ID: 26970635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
    Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
    Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog Signaling: From Basic Biology to Cancer Therapy.
    Wu F; Zhang Y; Sun B; McMahon AP; Wang Y
    Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.